Other specified interstitial pulmonary diseases
ICD-10 J84.89 is a billable code used to indicate a diagnosis of other specified interstitial pulmonary diseases.
J84.89 refers to 'Other specified interstitial pulmonary diseases,' which encompasses a variety of lung conditions characterized by inflammation and scarring of the lung tissue, leading to impaired gas exchange and respiratory function. Clinically, patients may present with symptoms such as progressive dyspnea, chronic cough, and fatigue. The interstitial lung diseases (ILDs) included under this code can result from various etiologies, including environmental exposures, autoimmune diseases, and idiopathic origins. The anatomy involved primarily includes the alveoli and interstitial spaces of the lungs, where the pathological changes occur. Disease progression can vary widely; some patients may experience rapid deterioration, while others may have a more indolent course. Diagnostic considerations typically involve imaging studies such as high-resolution computed tomography (HRCT) scans, pulmonary function tests, and sometimes lung biopsies to establish a definitive diagnosis. Given the complexity of ILDs, a multidisciplinary approach is often required for management, including pulmonologists, radiologists, and pathologists.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J84.89 encompasses various interstitial lung diseases not classified elsewhere, including but not limited to hypersensitivity pneumonitis, sarcoidosis, and drug-induced lung disease. Each condition has specific diagnostic criteria that must be met for appropriate coding.
J84.89 should be used when the interstitial pulmonary disease does not fit into more specific categories such as idiopathic pulmonary fibrosis (J84.1) or other defined interstitial lung diseases. It is essential to document the specific nature of the disease to justify the use of this code.
Documentation should include a comprehensive clinical history, results from imaging studies, pulmonary function tests, and any relevant laboratory findings. A clear description of the patient's symptoms and the rationale for the diagnosis is crucial.
